HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intensified adjunctive corticosteroid therapy for CNS tuberculomas.

AbstractINTRODUCTION:
Central nervous system (CNS) tuberculomas are a challenging manifestation of extrapulmonary tuberculosis often leading to neurological complications and post-treatment sequelae. The role of adjunctive corticosteroid treatment is not fully understood. Most guidelines on management of tuberculosis do not distinguish between tuberculous meningitis and CNS tuberculomas in terms of corticosteroid therapy.
METHODS:
We describe five patients with CNS tuberculomas who required intensified dexamethasone treatment for several months, in two cases up to 18 months.
RESULTS:
These patients were initially treated with the standard four-drug tuberculosis regimen and adjuvant dexamethasone. Neurological symptoms improved rapidly. However, multiple attempts to reduce or discontinue corticosteroids according to guideline recommendations led to clinical deterioration with generalized seizures or new CNS lesions. Thus, duration of adjunctive corticosteroid therapy was extended eventually leading to clinical cure and resolution of lesions.
CONCLUSION:
In contrast to tuberculous meningitis, the treatment for CNS tuberculomas appears to require a prolonged administration of corticosteroids. These findings need to be verified in controlled clinical studies.
AuthorsIsabelle Suárez, Henning Gruell, Jan Heyckendorf, Sarah Fünger, Thorsten Lichtenstein, Norma Jung, Clara Lehmann, Markus Unnewehr, Gerd Fätkenheuer, Christoph Lange, Jan Rybniker
JournalInfection (Infection) Vol. 48 Issue 2 Pg. 289-293 (Apr 2020) ISSN: 1439-0973 [Electronic] Germany
PMID31900872 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Adrenal Cortex Hormones
  • Antibiotics, Antitubercular
  • Dexamethasone
Topics
  • Adrenal Cortex Hormones (therapeutic use)
  • Adult
  • Aged
  • Antibiotics, Antitubercular (administration & dosage)
  • Combined Modality Therapy
  • Dexamethasone (administration & dosage)
  • Germany
  • Humans
  • Male
  • Middle Aged
  • Time Factors
  • Treatment Outcome
  • Tuberculoma (diagnostic imaging, drug therapy, pathology)
  • Tuberculosis, Central Nervous System (diagnostic imaging, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: